Prothena Corporation plc (NASDAQ:PRTA) is at least 35.92% than its current record low price of $8.63. There was a 4.27% gain on 01/11/2019 that led the price to move at $11.73. At recent session, the prices were hovering between $11.1 and $11.85. This company shares are 24.21% off its target price of $14.57 and the current market capitalization stands at $467.44M. The recent change has given its price a 2.53% lead over SMA 50 and -74.58% deficit over its 52-week high. The stock witnessed 0.86% gains, -4.17% declines and -21.28% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found PRTA’s volatility during a week at 5.58% and during a month it has been found around 7.29%.Prothena Corporation plc (PRTA) Top Holders
Institutional investors currently hold around $473 million or 0% in PRTA stock. Look at its top three institutional owners. Woodford Investment Management Ltd owns $139.88 million in Prothena Corporation plc, which represents roughly 29.92% of the company’s market cap and approximately 29.57% of the institutional ownership. Similar statistics are true for the second largest owner, Fmr Llc, which owns 5,042,364 shares of the stock are valued at $59.15 million. The third largest holder is Scopia Capital Management Lp, which currently holds $45.94 million worth of this stock and that ownership represents nearly 9.83% of its market capitalization.Prothena Corporation plc 13F Filings
At the end of September reporting period, 48 institutional holders increased their position in Prothena Corporation plc (NASDAQ:PRTA) by some 3,106,189 shares, 45 decreased positions by 4,212,980 and 46 held positions by 32,977,674. That puts total institutional holdings at 40,296,843 shares, according to SEC filings. The stock grabbed 19 new institutional investments totaling 471,546 shares while 13 institutional investors sold out their entire positions totaling 901,984 shares.Prothena Corporation plc (NASDAQ:PRTA) Insider Trades
Multiple company employees have indulged in significant insider trading. Prothena Corporation plc disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Selkoe Dennis J. has sold 3,500 shares of Prothena Corporation plc (PRTA) in trading session dated Oct. 02, 2017. These shares are worth $224,595 and were traded at $64.17 each. The SEC filing shows that Henney Christopher S performed a sale of 900 shares. The Director disposed these shares by way of transaction on Sep. 28, 2017. The company’s shares were given away at $70 per share worth to an income of some $63,000 on account of Henney Christopher S.
Chief Scientific Officer, Zago Wagner M., sold 900 common shares of Prothena Corporation plc (PRTA) in the open market. In a transaction dated Sep. 28, 2017, the shares were put up for sale at an average price of $70, raking in a sum of $63,000. After this sale, common shares of PRTA are directly owned by the insider, with total stake valued at $.
In the transaction dated Sep. 28, 2017, the great number of shares disposed came courtesy the President and CEO; Kinney Gene G. disposed a total of 2,800 shares at an average price of $70, amounting to approximately $196,000. The insider now directly owns 2,793 shares worth $32,762.Prothena Corporation plc (PRTA) Analyst Guide
Several analysts have released their opinion on Prothena Corporation plc (NASDAQ:PRTA), with 0 analysts believing it is a strong buy. Whereas 5 of them predict the stock is a hold. Also, there are 1 buy, 2 sell and 0 strong sell ratings, collectively assigning a 3.12 average brokerage recommendation.